Not surprising EMHTF is rebounding. Sales on the Ontario Cannabis Store are through the roof since Oct. 17th. They are making more sales than all other provinces combined.

Emerald management says they will be making in the hundreds of millions of dollars from the SunFarms joint venture with Village Farms. That represents a huge jump in revenues from 1 million the past year. That has got to garner a much higher share price. At the moment Emerald has over 70 million in cash so no near-term dilution.

EMHTF looks like it is putting in a triple bottom today. Rebounder very hard here. Time for the next massive run to start with earnings and explosive revenues coming.

sector wide sell-off in cannabis stocks. EMHTF is bottoming with higher low above mid $2 level. Uptrend should resume soon.

Watch for the bounce off 3.30. They have been saying sell this day....thankyou Cramer. Sell the sector and buy Canopy because that is the one to buy says Cramer. People are sheep. EMHTF will be $8 by December.

Emerald is a solid company. People will buy or sell whatever is promoted the most. MadMen appeared on Mad Money last night and they are up 10% when everything else is falling. EMHTF could see shares in the $30 range next year, double by end of this year. One earnings report away from a strong move up to end the year here....in my opinion.

In the sec filings yesterday Oncosec lists an intent to sell $5,471,763 worth of stock or warrants. This is listed under the Alpha Holdings Prospectus so I think this is set up for Alpha Holdings to max out their allowed ONCS holdings limit at 18.9% total. with the two placements agrred upon they have taken a 15% stake in ONCS. $5,471,763 odd dollar ammount looks like that would get them to 18.9%. Just my opinion here.

Emerald Health will be raking in profits soon. I like their strategy. When other larger companies such as Tilray and Canopy come up short of supply they will have to tap smaller companies to meet demand and pay a premium price to cover their supply agreements. That is probably why Emerald is taking their time signing additional province supply agreements.

Nice bounce back today. Looks like EMHTF is gapping up quickly.

Too many people focused on Tilray right now. Emerald still recovering from the selloff earlier this year based on British Columbia supply list....which they were not on until later than most expected. Patience is key here. It is a gem and very undervalued.

EMHTF should start to bounce right around now.

only fools selling EMHTF right now. Revenue will start pouring in soon.

EMHTF was probably due for a pullback like this. Setting up for the next run to higher highs. Only good news happening here. Loaded and waiting.

Emerald will very likely expand their Sun Farms capacity to 5 million sq. feet to meet demand next year. They are extremely undervalued right now.

beautiful chart....ready to breakout higher. Above $5 and EMHTF will uplist to Nasdaq or NYSE. It will happen by next month. Aurora already preparing to uplist next month. It is so obvious what is happening here.

EMHTF consolidation happening now. Should head right back to $4 soon. Chart looks amazingly bullish.

Tilray craziness created a buying opportunity in EMHTF. I added more yesterday. This will pass $5 soon and an uplisting will follow..... then higher prices after that.

Oncosec might be presenting a late breaking abstract for SITC. That is what they did last year. Also in 2016 they presented data as early as 3 months at SITC. PISCES data will be interim data so any positive data even at 3 months will be very good news. Most patients that respond to treatment do so by 3 months anyway. Not worried.....SITC is the "Superbowl" of oncology conferences...as stated by Oncosec's CEO......they will not miss it.

ONTX is about to go on a nice run.

EMHTF is a gift right now. When they uplist to Nasdaq they will get a much better share run. Just need to pass the $5 mark for a little bit and I believe uplisting will follow. They just mentioned doing that.

Oncosec is simply focused on the PISCES trial right now. With other trials set to start soon, I think presenting positive data at SITC will set the stage for strong momentum heading into 2019. The multi-gene candidate will be revealed. Head and Neck trial will start as well as a trial with Opdivo in melanoma. TNBC combo trial will likely start by end of this month.I think alot of things will start to unfold after SITC. Oncosec will probably present a late-breaking abstract like last year. I will be interested to hear any more news with the Avacta collaboration.

Anybody selling EMHTF right now are crazy. The trend is way too strong. Chart is excellent. I see this at the very least touching the past highs around $8 in the near-term.

The stock price is at a key level right now. If we bounce back higher today that would be a confirmation of the continued uptrend. I see it happening.

Emerald longs getting a great opportunity to add shares at a discount right now.

Probably see a big bounce today. That selloff was way overdone.

EMHTF simply needs to take a little breather here. It has been so strong the last few weeks. Still more than a month before the Oct. 17th date for legalization in Canada. I definitely see more runup to this date. I would expect further advances with any new provincial supply agreements or deals. I would hope EMHTF signs a supply agreement with Quebec soon.

This stock is so strong. I have never owned a stock that rebounds nicely off of every dip. Lovin' It. Happy to add more shares today. This is going to keep moving higher.

EMHTF looks like it is doing a quick consolidation before blowing past $4. Nice!

EMHTF getting ready to rip like Namaste. These are the few undervalued weed plays ready to catch up to the big boys.

More supply agreements coming for EMHTF by Oct. 17th.

So if Emerald Pharma eventually does an IPO how does that affect shareholders of EMHTF?

Are they all not under the same company. They are a subsidiary right?

http://wsw.com/webcast/rrshq28/register.aspx?conf=rrshq28&page=ehpi&url=http://wsw.com/webcast/rrshq28/ehpi/index.aspx

I just listened to the Emerald Health Pharma webcast with Jim DeMesa. I have to say I am very impressed with what they are working on. Multiple sclerosis (MS), scleroderma, Huntington's disease are the indications they are going after in the near-term. Proven effectiveness in animal trials and orphan drug status for 2 indications. They are planning a U.S. IPO within the next year and a half when they are into phase II human trials.

I would assume current holders of EMHTF will benefit when they IPO. If we are a $100 stock in 2 years a spinoff would be very lucrative at that point.

EMHTF should be like a $30 or $40 stock right now.

Absolutely stroke of genius Emerald had partnering with Village farms to create this Sun Farms JV. I expect they will expand operations to 5 million square feet. This will be an unstoppable freight train and probably the largest growing facility in the world.

Thanks!

Nice chart, where is that from?. That bodes well for Emerald. They are really positioning for huge growth. Now if Coke or Diageo would just sign a deal with Emerald we would rocket to the size of Canopy Growth.

The bonus is that Emerald has the option to expand to nearly 5 million square feet of space if they want to. This is so....$$$$$$

In the words of the Emerald CEO... "we are interested in getting the best deals, not the first deals, which is in the best interest of our shareholders"....reason why Emerald was not on the BC supply agreement list until one week later.....and probably why they were just added to the Ontario list. We have a good CEO in place, market needs to have a little more faith. Multi-Billion dollar company in the making right here.